Conventional and Genetic Evidence on the Association between Adiposity and CKD
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Significance Statement: Conventional epidemiology associates increased body mass index (BMI) with higher risk of CKD. Diabetes and high BP explain half of the association. However, residual confounding factors preclude causal inferences and impede mediation assessments. A genetic approach (Mendelian randomization) may overcome these limitations. Analyses of 281,228 genotyped UK Biobank participants identified positive independent genetic associations between central and general adiposity with CKD, suggesting both are causal risk factors. Conventional approaches underestimate the role of known mediators. Diabetes and BP (and correlates) explain >80% of genetic associations between waist-to-hip ratio and CKD and two-thirds between BMI and CKD. In people without diabetes, obesity appeared to cause CKD. BP accounted for about half of the BMI-CKD associations. Background: The size of any causal contribution of central and general adiposity to CKD risk and the underlying mechanism of mediation are unknown. Methods: Data from 281,228 UK Biobank participants were used to estimate the relevance of waist-to-hip ratio and body mass index (BMI) to CKD prevalence. Conventional approaches used logistic regression. Genetic analyses used Mendelian randomization (MR) and data from 394 waist-to-hip ratio and 773 BMI-associated loci. Models assessed the role of known mediators (diabetes mellitus and BP) by adjusting for measured values (conventional analyses) or genetic associations of the selected loci (multivariable MR). Results: Evidence of CKD was found in 18,034 (6.4%) participants. Each 0.06 higher measured waist-to-hip ratio and each 5-kg/m 2 increase in BMI were associated with 69% (odds ratio, 1.69; 95% CI, 1.64 to 1.74) and 58% (1.58; 1.55 to 1.62) higher odds of CKD, respectively. In analogous MR analyses, each 0.06–genetically-predicted higher waist-to-hip ratio was associated with a 29% (1.29; 1.20 to 1.38) increased odds of CKD, and each 5-kg/m 2 genetically-predicted higher BMI was associated with a 49% (1.49; 1.39 to 1.59) increased odds. After adjusting for diabetes and measured BP, chi-squared values for associations for waist-to-hip ratio and BMI fell by 56%. In contrast, mediator adjustment using multivariable MR found 83% and 69% reductions in chi-squared values for genetically-predicted waist-to-hip ratio and BMI models, respectively. Conclusions: Genetic analyses suggest that conventional associations between central and general adiposity with CKD are largely causal. However, conventional approaches underestimate mediating roles of diabetes, BP, and their correlates. Genetic approaches suggest these mediators explain most of adiposity-CKD–associated risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Trials of statin-based therapy, combined in collaborative meta-analyses, show a trend towards smaller relative reductions per mmol/L reduction in LDL-C on major atherosclerotic events as eGFR declines, with uncertainty about benefits among patients on dialysis.697”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [697]
In the citing paper
“Statin-based therapy reduces the risk of major atherosclerotic events (i.e.coronary death, non-fatal MI, ischaemic stroke, and coronary revascularization) in patients with CKD, but does not meaningfully slow progression of CKD.248,[697][698][699]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [697]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 1×
“SBP (mmHg) 138 (17) 140 (17) 142 (17) 143 (17) 143 (17) 141 (17) 141 (17) 141 (17) 141 (17) 142 (17) 141 (17)”
Self-citationNg, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
Verbanck, M., Chen, C.-Y., Neale, B., & Do, R. (2018) · Nature Genetics · doi:10.1038/s41588-018-0099-7 · Cited by 8,591
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Yengo, L., Sidorenko, J., Kemper, K. E., Zheng, Z., Wood, A. R., Weedon, M. N., Frayling, T. M., Hirschhorn, J., Yang, J., Visscher, P. M., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy271 · Cited by 2,367
Burgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
A review of instrumental variable estimators for Mendelian randomization
Burgess, S., Small, D. S., & Thompson, S. G. (2017) · Statistical Methods in Medical Research · doi:10.1177/0962280215597579 · Cited by 1,764
the GIANT Consortium (2009) · Nature Genetics · doi:10.1038/ng.287 · Cited by 1,720
Burgess, S., & Thompson, S. G. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwu283 · Cited by 1,605
New genetic loci link adipose and insulin biology to body fat distribution
The ADIPOGen Consortium, Shungin, D., The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GEFOS Consortium, The GENIE Consortium, The, G. L. G. C., The, I. C. B. P., The International Endogene Consortium, Study, T. L. C., et al. (2015) · Nature · doi:10.1038/nature14132 · Cited by 1,580
Body Mass Index and Risk for End-Stage Renal Disease
Hsu, C.-Y., McCulloch, C. E., Iribarren, C., Darbinian, J., & Go, A. S. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00006 · Cited by 1,390
Pulit, S. L., Stoneman, C., Morris, A. P., Wood, A. R., Glastonbury, C. A., Tyrrell, J., Yengo, L., Ferreira, T., Marouli, E., Ji, Y., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy327 · Cited by 1,163
(2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,114
Self-citationBowden, J., Del Greco M, F., Minelli, C., Zhao, Q., Lawlor, D. A., Sheehan, N. A., Thompson, J., & Davey Smith, G. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy258 · Cited by 995
Xie, X., Atkins, E., Lv, J., Bennett, A., Neal, B., Ninomiya, T., Woodward, M., MacMahon, S., Turnbull, F., Hillis, G. S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00805-3 · Cited by 980
Self-citationNational, regional, and global trends in adult overweight and obesity prevalences
Stevens, G. A., Singh, G. M., Lu, Y., Danaei, G., Lin, J. K., Finucane, M. M., Bahalim, A. N., McIntire, R. K., Gutierrez, H. R., Cowan, M., et al. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-22 · Cited by 929
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Self-citationLv, J., Neal, B., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S., Turnbull, F., Hillis, G., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001293 · Cited by 777
Self-citationAn Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans
Scott, R. A., Scott, L. J., Mägi, R., Marullo, L., Gaulton, K. J., Kaakinen, M., Pervjakova, N., Pers, T. H., Johnson, A. D., Eicher, J. D., et al. (2017) · Diabetes · doi:10.2337/db16-1253 · Cited by 736
Body mass index and the risk of development of end-stage renal disease in a screened cohort
Iseki, K., Ikemiya, Y., Kinjo, K., Inoue, T., Iseki, C., & Takishita, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00582.x · Cited by 603
Study, T. L. C., Day, F. R., The InterAct Consortium, kConFab/AOCS Investigators, Endometrial Cancer Association Consortium, Ovarian Cancer Association Consortium, PRACTICAL consortium, Thompson, D. J., Helgason, H., Chasman, D. I., et al. (2017) · Nature Genetics · doi:10.1038/ng.3841 · Cited by 587
CHARGE-EchoGen Consortium, Ehret, G. B., CHARGE-HF Consortium, Wellcome Trust Case Control Consortium, Ferreira, T., Chasman, D. I., Jackson, A. U., Schmidt, E. M., Johnson, T., Thorleifsson, G., et al. (2016) · Nature Genetics · doi:10.1038/ng.3667 · Cited by 420
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., & Collins, R. (2005) · UCL Discovery (University College London) · Cited by 324
Self-citationBody Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease
Vivante, A., Golan, E., Tzur, D., Leiba, A., Tirosh, A., Skorecki, K., & Calderon-Margalit, R. (2012) · Archives of Internal Medicine · doi:10.1001/2013.jamainternmed.85 · Cited by 321
(2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70156-1 · Cited by 319
Waist-to-Hip Ratio, Body Mass Index, and Subsequent Kidney Disease and Death
Elsayed, E. F., Sarnak, M. J., Tighiouart, H., Griffith, J. L., Kurth, T., Salem, D. N., Levey, A. S., & Weiner, D. E. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.363 · Cited by 261 · cited 2×
“3% SBP, mm Hg 138 (19) 135 141 6 138 139 1 DBP, mm Hg 82 (10) 79 85 5 82 83 1”
Chang, A. R., Grams, M. E., Ballew, S. H., Bilo, H., Correa, A., Evans, M., Gutierrez, O. M., Hosseinpanah, F., Iseki, K., Kenealy, T., et al. (2019) · BMJ · doi:10.1136/bmj.k5301 · Cited by 233
Self-citationAssociation of age and BMI with kidney function and mortality: a cohort study
Lu, J. L., Molnar, M. Z., Naseer, A., Mikkelsen, M. K., Kalantar-Zadeh, K., & Kovesdy, C. P. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00128-x · Cited by 223
Causal relationships between obesity and the leading causes of death in women and men
Censin, J. C., Peters, S. A. E., Bovijn, J., Ferreira, T., Pulit, S. L., Mägi, R., Mahajan, A., Holmes, M. V., & Lindgren, C. M. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008405 · Cited by 203
Mendelian randomisation in cardiovascular research: an introduction for clinicians
Bennett, D. A., & Holmes, M. V. (2017) · Heart · doi:10.1136/heartjnl-2016-310605 · Cited by 178
Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’
Keavney, B., Danesh, J., Parish, S., Palmer, A., Clark, S., Youngman, L., Delépine, M., Lathrop, M., Peto, R., & Collins, R. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl114 · Cited by 142
Herrington, W. G., Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D. R., Coresh, J., & Woodward, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173515 · Cited by 141
Self-citationImpaired fasting glucose is associated with renal hyperfiltration in the general population
Melsom, T., Mathisen, U. D., Ingebretsen, O. C., Jenssen, T. G., Njølstad, I., Solbu, M. D., Toft, I., & Eriksen, B. O. (2011) · Diabetes Care · doi:10.2337/dc11-0235 · Cited by 134
GWAS for BMI: a treasure trove of fundamental insights into the genetic basis of obesity
Speakman, J. R., Loos, R. J. F., O’Rahilly, S., Hirschhorn, J. N., & Allison, D. B. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0147-5 · Cited by 109
Xie, X., Atkins, E., & Lv, J. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2016.08.069 · Cited by 107
Ko, Y.-A., Yi, H., Qiu, C., Huang, S., Park, J., Ledó, N., Köttgen, A., Li, H., Rader, D. J., Pack, M. A., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.05.004 · Cited by 102
Bowden, J., Fabiola Del Greco, M., Minelli, C., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/159442 · Cited by 102
Grams, M. E., Juraschek, S. P., Selvin, E., Foster, M. C., Inker, L. A., Eckfeldt, J. H., Levey, A. S., & Coresh, J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.013 · Cited by 99
Herrington, W. G., Alegre-Díaz, J., Wade, R. L., Gnatiuc, L., Ramírez-Reyes, R., Hill, M., Solano-Sánchez, M., Baigent, C., Lewington, S., Collins, R., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30050-0 · Cited by 95
Self-citationStefansson, V. T. N., Schei, J., Jenssen, T. G., Melsom, T., & Eriksen, B. O. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0386-4 · Cited by 62
Biomarkers of inflammation predict both vascular and non-vascular mortality in older men
Clarke, R., Emberson, J. R., Breeze, E., Casas, J. P., Parish, S., Hingorani, A. D., Fletcher, A., Collins, R., & Smeeth, L. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn049 · Cited by 59
Self-citationWormser, D., White, I. R., Thompson, S. G., & Wood, A. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt077 · Cited by 23
Mafham, M. M., Staplin, N., Emberson, J., Haynes, R., Herrington, W. G., Reith, C. A., Wanner, C., Walker, R. J., Cass, A., Levin, A., et al. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw396 · Cited by 13
Self-citation
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citation2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationObesity and chronic kidney disease
Jiang, Z., Wang, Y., Zhao, X., Cui, H., Han, M., Ren, X., Gang, X., & Wang, G. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2022 · Cited by 267
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Colhoun, H. M., Lingvay, I., Brown, P. M., Deanfield, J., Brown-Frandsen, K., Kahn, S. E., Plutzky, J., Node, K., Parkhomenko, A., Rydén, L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03015-5 · Cited by 238
Obesity‐related glomerulopathy: Current approaches and future perspectives
Martínez‐Montoro, J. I., Morales, E., Cornejo-Pareja, I. M., Tinahones, F. J., & Fernández‐García, J. C. (2022) · Obesity Reviews · doi:10.1111/obr.13450 · Cited by 145
“Urinary podocin and nephrin (as well as urinary podocin/nephrin ratio) are specific markers of glomerular podocyte injury/stress and are associated with the progression of CKD.77–79 Urinary podocalyxin (PCX), a podocyte surface antigen, was elevated in subjects with obesity and a normal eGFR and urinary albumin/creati…”
BackgroundInfluential
Metadata
- Authors
- Zhu, P., Herrington, W. G., Haynes, R., Emberson, J., Landray, M. J., Sudlow, C. L. M., Woodward, M., Baigent, C., Lewington, S., & Staplin, N.
- Affiliations
- University of Oxford (GB)
- Churchill Hospital (GB)
- National Institute for Health and Care Research (GB)
- University of Edinburgh (GB)
- Johns Hopkins University (US)
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2020-10-30
- Volume
- 32
- Issue
- 1
- Pages
- 127-137
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- PMC
- PMC7894659
- OpenAlex
- W3096101149
- Cited by
- 83
- References
- 47
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 16 · 2023: 20 · 2022: 10 · 2021: 9 · 2020: 1
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- Funders
- Medical Research Council (MR/R007764/1)
- Kidney Research UK (MR/R007764/1)
- Boehringer Ingelheim
- British Heart Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- chronic kidney disease, adiposity, body mass index, waist-to-hip ratio, abdominal obesity, obesity, diabetes mellitus, blood pressure, mediation analysis, causal inference, genetic loci, Mendelian randomization, multivariable Mendelian randomization, residual confounding, UK Biobank, genetic risk factors, renal function decline, chronic kidney disease progression
- MeSH terms
- Adult, Aged, Algorithms, Female, Genotype, United Kingdom, Humans, Male, Middle Aged, Obesity, Prospective Studies, Risk Factors, Body Mass Index, Prevalence, Genetic Predisposition to Disease, Waist-Hip Ratio, Adiposity, Renal Insufficiency, Chronic, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.